Phase II trial of hypericin photodynamic therapy in patients with cutaneous T-cell lymphoma

Trial Profile

Phase II trial of hypericin photodynamic therapy in patients with cutaneous T-cell lymphoma

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Feb 2017

At a glance

  • Drugs Hypericin (Primary)
  • Indications Cutaneous T cell lymphoma
  • Focus Therapeutic Use
  • Sponsors HY BIOPHARMA
  • Most Recent Events

    • 16 Sep 2014 New trial record
    • 05 Sep 2014 Results published in the Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top